Filing Details

Accession Number:
0001144204-14-019652
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-31 18:09:08
Reporting Period:
2014-03-28
Filing Date:
2014-03-31
Accepted Time:
2014-03-31 18:09:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591950 Maher Albitar 12701 Commonwealth Drive Suite 9
Fort Myers FL US 33913
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-28 14,492 $3.51 48,492 No 4 P Indirect Albitar Oncology Defined Benefit Plan owns shares
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Albitar Oncology Defined Benefit Plan owns shares
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to buy) $1.43 2013-01-09 2017-01-09 250,000 250,000 Direct
Common Stock Warrants (Right to Buy) $1.43 2017-01-09 2017-01-09 200,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-01-09 250,000 250,000 Direct
2017-01-09 200,000 200,000 Direct
Footnotes
  1. These stock options were granted upon the start of Mr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.
  2. These warrants were issued to Mr. Albitar upon the start of his service to the Company and vest upon the acheivement of certain currently unmet milestones.